Venus Pipes & Tubes Limited (VENUSPIPES) has initiated pipe spooling operations ahead of schedule, marking a significant milestone in its expansion strategy. The early commencement of these operations in Dhaneti, Gujarat, is set to bolster the company’s value-added piping solutions portfolio. By starting production ahead of the originally planned timeline of December 2026, the company aims to establish manufacturing readiness in advance of anticipated customer orders, enabling faster execution and dispatch once orders are received.

Strategic Milestone

The proactive step to commence pipe spooling operations ahead of schedule underscores the company’s commitment to expanding its participation in the growing data centre infrastructure segment. Arun Kothari, Managing Director of Venus Pipes & Tubes Limited, highlighted that this initiative will help reduce lead times and facilitate quicker responses to customer requirements. The company has already received a Letter of Intent (LOI) worth Rs. 185 crore from a data centre customer for pipe spooling solutions, with the conversion into firm orders expected to begin in the coming days.

Future Plans

The early operationalization of the dedicated pipe spooling manufacturing capacity is planned to be completed in a phased manner over the next few months. This strategic move is anticipated to strengthen the company’s ability to meet customer demands efficiently and expand its market presence in the data centre infrastructure sector. With this milestone, Venus Pipes & Tubes Limited is well-positioned to capitalize on the growing demand for advanced piping solutions.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Venus Pipes & Tubes Limited

Venus Pipes & Tubes Limited belongs to the Basic Materials › Steel sector. Here’s a quick read on where the business and the stock stand today.

Venus posts a 11.7% three-month gain, but softens in the last few weeks. Thin margins at 8.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue grows at 26.8% and profits at 32.1% CAGR. Both numbers are exceptional. The stock gives back 1.5% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Both the business and the stock move in the right direction. Revenue grows at 26.8%, profits at 32.1%, and the PEG sits at 1.18 — below its growth rate. That combination is rare. Check Fundamentals of Venus Pipes & Tubes Limited.

Hindustan Zinc Limited (HINDZINC), the world’s largest integrated zinc producer, announces record results for the second quarter and half year ended September 30, 2026. The company reported a net profit of ₹6,412 crore, up 142% year-on-year (YoY), driven by a robust increase in mined and refined metal production, higher metal prices, and a stronger dollar.

Record Production and Profitability

The company achieved a record second quarter mined metal production of 271 thousand tonnes (KT), up 5% YoY. Refined metal production also reached a best-ever 264 KT, up 7% YoY. Zinc cost of production excluding royalty was $703 per tonne, better by 29% YoY, due to improved mined grades and increased metal production.

Financial Highlights

Revenue from operations stood at ₹15,093 crore during the quarter, up 77% YoY. The company’s earnings before interest, taxes, depreciation, and amortization (EBITDA) stood at ₹9,285 crore, up 108% YoY. The industry-leading EBITDA margin was maintained at 62%.

Forward-Looking Statement

Commenting on the company’s performance, Amarendu Prakash, Chief Executive Officer, said: “I am honored to lead Hindustan Zinc at this pivotal stage. Our record quarterly mined metal production of 271 KT and refined metal production of 264 KT demonstrates the strength of our operations, assets, and people. We remain focused on disciplined growth, AI-led innovation, and advancing our critical minerals portfolio to support India’s energy transition while delivering long-term stakeholder value.”

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Hindustan Zinc Limited

Hindustan Zinc Limited belongs to the Basic Materials › Other Industrial Metals & Mining sector. Here’s a quick read on where the business and the stock stand today.

Hindustan posts a 4.2% three-month gain, but softens in the last few weeks. Industry-leading margins of 38.1% reflect exceptional pricing power and operational efficiency. The PEG of 1.40 sits close to fair value. The stock is neither a clear buy nor obviously expensive. The stock gives back 4.8% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 5.6% and profits at 9.6%, and the dividend yield stands at 2.07%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of Hindustan Zinc Limited.

Rossari Biotech Limited (ROSSARI) has announced its unaudited financial results for the quarter and half-year ended September 30, 2026, marking a significant milestone with the highest-ever quarterly revenue and EBITDA. The company reported a record quarterly revenue of Rs. 697.6 crores, a 19.0% growth on a year-on-year basis, and an EBITDA of Rs. 87.0 crores, a 20.9% growth on a year-on-year basis.

Record Financial Performance

The company’s consolidated Q2 FY27 performance highlights include: highest-ever quarterly revenue of Rs. 697.6 crores, highest-ever quarterly EBITDA of Rs. 87.0 crores, and an EBITDA margin of 12.5%, up by 20 bps. Despite higher depreciation due to investments in long-term projects, the Profit After Tax stood at Rs. 38.9 crores. Additionally, export sales reached Rs. 216.4 crores, a 33.8% growth on a year-on-year basis.

Strategic Growth Initiatives

Rossari Biotech Limited has also made significant progress in its strategic initiatives. The Board has approved the leasing of land for setting up a greenfield manufacturing facility in the Kingdom of Saudi Arabia (KSA). This marks a key milestone in Rossari’s international growth journey. The company continues to focus on strengthening its balance sheet and improving cash flow generation, with net working capital cycle improved to 86 days as of September 2026 from 97 days as of March 2026.

With strong R&D capabilities, expanding capacities, a healthy balance sheet, and a growing global footprint, Rossari Biotech Limited is well-positioned to deliver sustained long-term growth.

Source: NSE Corporate Announcement

Fundamental & Technical Analysis of Rossari Biotech Limited

Rossari Biotech Limited belongs to the Basic Materials › Specialty Chemicals sector. Here’s a quick read on where the business and the stock stand today.

Rossari falls 14.4% over three months and has not found a floor yet. Thin margins at 5.9% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Not a single revenue dip or loss quarter in five years — this is a business built to last through cycles. The stock gains 3.9% in the last month, recovering from the three-month slide. However, it is too early to call this a confirmed reversal. Revenue grows at 13.1% and profits at 11.6% CAGR, with D/E of 0.18. Meanwhile, the stock dips 14.4% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Rossari Biotech Limited.